The term “immunobiotics” has been proposed to define microbial strains able to beneficially regulate the mucosal immune system. Research in immunobiotics has significantly evolved as researchers employed cutting-edge technologies to investigate the complex interactions of these beneficial microorganisms with the immune system. During the last decade, our understanding of immunobiotics-host interaction was profoundly transformed by the discovery of microbial molecules and host receptors involved in the modulation of gut associated immune system, as well as the systemic and distant mucosal immune systems.
In recent years, there has been a substantial increase in the number of reports describing the beneficial effects of immunobiotics in diseases such as intestinal and respiratory infections, allergy, inflammatory bowel disease, obesity, immunosuppression, and several other immune-mediated conditions. Evidence is also emerging of immunobiotics related molecules with immunomodulatory functions leading to the production of pharmabiotics, which may positively influence human or animal health. Therefore, research in immunobiotics continue to contribute not only to food but also medical and pharmaceutical fields.
In this Frontiers Research Topic, we will explore the cellular and molecular interactions of immunobiotics and their immunomodulatory components with mucosal epithelial cells and immune cells, focusing on the impact of those interactions on the prevention or treatment of diseases. We will also examine new possible areas where immunobiotics might be useful for preventing diseases as well as future directions in their immunobiotechnological applications.
We will welcome original research articles, reviews articles and opinion pieces.
The term “immunobiotics” has been proposed to define microbial strains able to beneficially regulate the mucosal immune system. Research in immunobiotics has significantly evolved as researchers employed cutting-edge technologies to investigate the complex interactions of these beneficial microorganisms with the immune system. During the last decade, our understanding of immunobiotics-host interaction was profoundly transformed by the discovery of microbial molecules and host receptors involved in the modulation of gut associated immune system, as well as the systemic and distant mucosal immune systems.
In recent years, there has been a substantial increase in the number of reports describing the beneficial effects of immunobiotics in diseases such as intestinal and respiratory infections, allergy, inflammatory bowel disease, obesity, immunosuppression, and several other immune-mediated conditions. Evidence is also emerging of immunobiotics related molecules with immunomodulatory functions leading to the production of pharmabiotics, which may positively influence human or animal health. Therefore, research in immunobiotics continue to contribute not only to food but also medical and pharmaceutical fields.
In this Frontiers Research Topic, we will explore the cellular and molecular interactions of immunobiotics and their immunomodulatory components with mucosal epithelial cells and immune cells, focusing on the impact of those interactions on the prevention or treatment of diseases. We will also examine new possible areas where immunobiotics might be useful for preventing diseases as well as future directions in their immunobiotechnological applications.
We will welcome original research articles, reviews articles and opinion pieces.